NO162821C - Fremgangsmaate for fremstilling av terapeutisk aktive furo-pyridinderivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive furo-pyridinderivater.

Info

Publication number
NO162821C
NO162821C NO853782A NO853782A NO162821C NO 162821 C NO162821 C NO 162821C NO 853782 A NO853782 A NO 853782A NO 853782 A NO853782 A NO 853782A NO 162821 C NO162821 C NO 162821C
Authority
NO
Norway
Prior art keywords
furo
procedure
preparation
group
pyridine derivatives
Prior art date
Application number
NO853782A
Other languages
English (en)
Norwegian (no)
Other versions
NO853782L (no
NO162821B (no
Inventor
Alexander Wick
Jonathan Frost
Jean Bertin
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO853782L publication Critical patent/NO853782L/no
Publication of NO162821B publication Critical patent/NO162821B/no
Publication of NO162821C publication Critical patent/NO162821C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Mushroom Cultivation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO853782A 1984-09-27 1985-09-26 Fremgangsmaate for fremstilling av terapeutisk aktive furo-pyridinderivater. NO162821C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8414842A FR2570701B1 (fr) 1984-09-27 1984-09-27 Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
NO853782L NO853782L (no) 1986-04-01
NO162821B NO162821B (no) 1989-11-13
NO162821C true NO162821C (no) 1990-02-21

Family

ID=9308136

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853782A NO162821C (no) 1984-09-27 1985-09-26 Fremgangsmaate for fremstilling av terapeutisk aktive furo-pyridinderivater.

Country Status (19)

Country Link
US (1) US4661498A (es)
EP (1) EP0178201B1 (es)
JP (1) JPS61106577A (es)
KR (1) KR860002508A (es)
AT (1) ATE40554T1 (es)
AU (1) AU573390B2 (es)
CA (1) CA1291994C (es)
DE (1) DE3568045D1 (es)
DK (1) DK158953C (es)
ES (1) ES8605522A1 (es)
FI (1) FI82054C (es)
FR (1) FR2570701B1 (es)
GR (1) GR852356B (es)
HU (1) HU192365B (es)
IL (1) IL76535A0 (es)
NO (1) NO162821C (es)
NZ (1) NZ213620A (es)
PT (1) PT81206B (es)
ZA (1) ZA857457B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2566775B1 (fr) * 1984-06-27 1986-10-31 Synthelabo Derives de tetrahydro-4,5,6,7 furo ou 1h-pyrrolo(2,3-c)pyridine, leur preparation et leur application en therapeutique
FR2619112B1 (fr) * 1987-08-07 1989-11-17 Synthelabo Derives de (piperidinyl-4)methyl-2 benzo(b)furo(2,3-c) pyridines, leur preparation et leur application en therapeutique
FR2635977B1 (fr) * 1988-09-07 1992-05-15 Synthelabo Utilisation de derives de tetrahydro-4,5,6,7 furopyridines pour obtenir des medicaments destines au traitement de l'obesite
US5795784A (en) 1996-09-19 1998-08-18 Abbott Laboratories Method of performing a process for determining an item of interest in a sample
US5856194A (en) 1996-09-19 1999-01-05 Abbott Laboratories Method for determination of item of interest in a sample
UA52681C2 (uk) * 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі
UA70334C2 (en) 1998-10-06 2004-10-15 Janssen Pharmaceutica N V Jans BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS
ID28967A (id) * 1998-12-21 2001-07-19 Janssen Pharmaceutica Nv Benzisoksazol dan fenon sebagai alfa 2-antagonis
WO2000043397A1 (en) * 1999-01-19 2000-07-27 Neurosearch A/S Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215948B1 (es) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma
DD210278A5 (de) * 1982-03-05 1984-06-06 Boehringer Ingelheim Kg Verfahren zur herstellung neuer basisch substituierter 4-phenyl-4,5,6,7-tetrahydro-thieno-(2,3-c)pyridine

Also Published As

Publication number Publication date
US4661498A (en) 1987-04-28
ES8605522A1 (es) 1986-03-16
DK158953B (da) 1990-08-06
NO853782L (no) 1986-04-01
FR2570701A1 (fr) 1986-03-28
PT81206B (pt) 1988-01-22
ES547315A0 (es) 1986-03-16
GR852356B (es) 1986-01-28
DE3568045D1 (en) 1989-03-09
AU573390B2 (en) 1988-06-09
DK435285A (da) 1986-03-28
FI82054B (fi) 1990-09-28
AU4795285A (en) 1986-04-10
HU192365B (en) 1987-05-28
CA1291994C (en) 1991-11-12
FI853719A0 (fi) 1985-09-26
DK158953C (da) 1991-01-14
HUT38945A (en) 1986-07-28
FI82054C (fi) 1991-01-10
DK435285D0 (da) 1985-09-26
FR2570701B1 (fr) 1987-05-22
ZA857457B (en) 1986-05-28
IL76535A0 (en) 1986-02-28
ATE40554T1 (de) 1989-02-15
KR860002508A (ko) 1986-04-26
JPS61106577A (ja) 1986-05-24
EP0178201B1 (fr) 1989-02-01
EP0178201A1 (fr) 1986-04-16
FI853719L (fi) 1986-03-28
NZ213620A (en) 1988-01-08
NO162821B (no) 1989-11-13
PT81206A (fr) 1985-10-01

Similar Documents

Publication Publication Date Title
NO166126C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
NO883994L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinylaminer.
DK53285A (da) (-)-trans-4(4-fluorphenyl)-3-(4-methoxyphenoxy)-methylpiperidin, farmaceutisk acceptable syreadditionssalte heraf og farmaceutisk praeparat indeholdende samme
NO162821C (no) Fremgangsmaate for fremstilling av terapeutisk aktive furo-pyridinderivater.
DK527984D0 (da) 11-substituerede 5h,11h-pyrrolo(2,1-c)(1,4)benzoxazepiner eller farmaceutisk acceptable salte deraf, deres fremstilling og mellemprodukter hertil samt deres anvendelse som antipsychotika og analgetika
DK408083A (da) Isoquinolinderivater, deres fremstilling og anvendelse
DE3564684D1 (en) Tetrahydrothienopyridines, process for their preparation and their pharmaceutical application
PH25106A (en) 1-acyl-3-(4-(2-pyrimidinyl)-1-piperazinyl) propanes, pharmaceutical composition containing said compound and method of use thereof
NO167286C (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-derivater.
NO170580C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater
DK148288A (da) N-phenethylaminoalkyl-benzamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende forbindelserne
NO169442C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive prolinderivater og lignende forbindelser
ATE47135T1 (de) Antikonvulsive mittel.
NO164901C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetraoxo-3,7-diazabicyclo (3,3,1)-nonanforbindelser.
DK364386A (da) 1-alkyl-ergolinyl-thiourinstofderivater og fremgangsmaade til fremstilling deraf samt deres anvendelse
ES2004255A6 (es) Procedimiento de preparar compuestos del tipo de las piracinas y analogos.
DK74594A (da) Fremgangsmåde til fremstilling af paroxetin eller et farmaceutisk acceptabelt salt deraf
SE8802162D0 (sv) Nya aminoacylater av glycerolacetal